Yiling Lu
Researcher Next ID · RN-020675
Researcher · Biochemistry, Genetics and Molecular Biology
Shanghai, China
- Works count
- 810
- Citation count
- 142,507
- H-index
- 133
- i10-index
- 303
Research interests
Publications
Next-generation characterization of the Cancer Cell Line Encyclopedia
Nature · 2019 · https://doi.org/10.1038/s41586-019-1186-3
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
Cell · 2018 · https://doi.org/10.1016/j.cell.2018.03.022
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
Cancer Cell · 2018 · https://doi.org/10.1016/j.ccell.2018.03.010
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Cell Reports · 2018 · https://doi.org/10.1016/j.celrep.2018.03.075
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Cell · 2018 · https://doi.org/10.1016/j.cell.2018.02.052
Comprehensive Characterization of Cancer Driver Genes and Mutations
Cell · 2018 · https://doi.org/10.1016/j.cell.2018.02.060
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Nature · 2018 · https://doi.org/10.1038/s41586-018-0392-8
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Cell · 2018 · 10.1016/j.cell.2018.03.034
Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types
Cell Reports · 2018 · 10.1016/j.celrep.2018.01.088
Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
Cell Reports · 2018 · 10.1016/j.celrep.2018.03.086
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
Cancer Cell · 2018 · 10.1016/j.ccell.2018.07.001
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
Cell Systems · 2018 · 10.1016/j.cels.2018.03.002
Pathogenic Germline Variants in 10,389 Adult Cancers
Cell · 2018 · 10.1016/j.cell.2018.03.039
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
Cell Reports · 2018 · 10.1016/j.celrep.2018.03.050
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Cell Reports · 2018 · 10.1016/j.celrep.2018.10.001
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer
Cancer Cell · 2018 · 10.1016/j.ccell.2018.03.006
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
Cell Reports · 2018 · 10.1016/j.celrep.2018.03.076
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Cancer Cell · 2018 · 10.1016/j.ccell.2018.03.007
Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
Cell Reports · 2018 · 10.1016/j.celrep.2018.03.086
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
Cancer Cell · 2017 · 10.1016/j.ccell.2017.07.003
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
Cell · 2017 · 10.1016/j.cell.2017.09.007
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Cancer Cell · 2017 · 10.1016/j.ccell.2017.07.007
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Cell · 2015 · 10.1016/j.cell.2015.09.033
A pan-cancer proteomic perspective on The Cancer Genome Atlas
Nature Communications · 2014 · 10.1038/ncomms4887
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Nature Reviews Drug Discovery · 2005 · 10.1038/nrd1902
PIK3CA is implicated as an oncogene in ovarian cancer
Nature Genetics · 1999 · 10.1038/5042
Current projects
No projects listed.